Vironexis Biotherapeutics

Vironexis Biotherapeutics is a biotechnology company focused on advancing immunotherapy for cancer treatment. It specializes in AAV-delivered T-cell immunotherapy, utilizing a gene therapy platform that allows for the development of off-the-shelf, single-dose gene therapies. This innovative approach aims to enhance the effectiveness of cancer treatments by enabling healthcare professionals to improve patient outcomes through T-cell-mediated cancer eradication. Vironexis holds the potential to significantly change the landscape of cancer therapy in the future.